Active ingredient
Pimavanserin
3 finished FDA listings contain Pimavanserin as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- PIMAVANSERIN TARTRATE
- Dosage forms
- Capsule, Tablet, Coated
- Routes
- Oral
- Manufacturers / labelers
- 2
- Strengths listed
- 10 mg/1 · 34 mg/1
- Brand names in FDA listings
- Nuplazid
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 1791685
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 207318 | ACADIA PHARMS INC | 2016-04-29 | 1 |
| NDA 210793 | ACADIA PHARMS INC | 2018-06-28 | 1 |
| ANDA 214925 | MSN | 2024-01-16 | 1 |
Official labeling on DailyMed
- NUPLAZID (PIMAVANSERIN TARTRATE) CAPSULE NUPLAZID (PIMAVANSERIN TARTRATE) TABLET, COATED [ACADIA PHARMACEUTICALS INC.] · version 23 · 2026-06-22
- PIMAVANSERIN CAPSULE [NOVADOZ PHARMACEUTICALS LLC] · version 1 · 2025-12-23
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.